Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Hematology & Oncology
Published in: Journal of Hematology & Oncology 1/2009

Open Access 01-12-2009 | Letter to the Editor

Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation

Authors: Yuan Yuan, Rosemary Wieczorek, David L Green, Perry Cook, Harold Ballard, David J Araten

Published in: Journal of Hematology & Oncology | Issue 1/2009

Login to get access

Abstract

Pulmonary involvement and skin involvement are rare complications of plasma cell neoplasms. Here we describe what may be the first reported case of a patient with relapse in both of these sites following autologous peripheral blood stem cell transplantation.
Appendix
Available only for authorised users
Literature
1.
Kintzer J, Rosenow E, Kyle R: Thoracic and Pulmonary Abnormalities in Multiple Myeloma. Archives of Internal Medicine. 1978, 138: 727-730. 10.1001/archinte.138.5.727.CrossRefPubMed
2.
Chejfec G, Natarelli J, Gould V: Myeloma lung: a previously unreported complication of multiple myeloma. Human Pathology. 1983, 14: 558-561. 10.1016/S0046-8177(83)80008-2.CrossRefPubMed
3.
Schelle M, Schreiber C, Florschutz A, Kachel R, Schreiber J: Pulmonary and pleural manifestations of multiple myeloma. Pneumologie. 2006, 60: 743-748. 10.1055/s-2006-944275.CrossRefPubMed
4.
Yokote T, Akioka T, Miyamoto H, Oka S, Hara S, Yamano T, Takasu T, Tsuji M, Hanafusa T: Pulmonary parenchymal infiltrates in a patient with CD20-positive multiple myeloma. European Journal of Haematology. 74: 61-65. 10.1111/j.1600-0609.2004.00326.x.
5.
6.
Gabriel S: Multiple myeloma presenting as pulmonary infiltration. Dis Chest. 1965, 47: 123-136. 10.1378/chest.47.1.123.CrossRefPubMed
7.
Gozdziuk K, Kedra M, Ryojad P, Sagam D: A rare case of solitary plasmacytoma mimicking a primary lung tumor. Annals Thoracic Surg. 2009, 87: 25-26. 10.1016/j.athoracsur.2008.11.066.CrossRef
8.
Kamble R, Rosenzweig T: Diffuse pulmonary parenchymal involvement in multiple myeloma: antemortem diagnosis. International Journal of Hematology. 2006, 83: 259-261. 10.1532/IJH97.05002.CrossRefPubMed
9.
Gambichler T, Othlinghaus N, Stucker M, Altmeyer P, AKCaE : Dermatology Cutaneous giant plasmacytoma associated with monoclonal gammopathy of unknown significance. Clinical and Experimental Dermatology. 2009, 34: 417-418. 10.1111/j.1365-2230.2008.02956.x.CrossRefPubMed
10.
Walzer R, Shapiro L: Multiple Myeloma with Cutaneous Involvement. Dermatologica. 1967, 134: 449-454. 10.1159/000254288.CrossRefPubMed
Metadata
Title
Multiple Myeloma Involving Skin and Pulmonary Parenchyma after Autologous Stem Cell Transplantation
Authors
Yuan Yuan
Rosemary Wieczorek
David L Green
Perry Cook
Harold Ballard
David J Araten
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2009
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-2-48

Other articles of this Issue 1/2009

Journal of Hematology & Oncology 1/2009 Go to the issue

Review

Recent advances of novel targeted therapy in non-small cell lung cancer

Research

Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study

Review

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Case report

Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report

Review

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics

Review

New targets for the treatment of follicular lymphoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits